Anti-vista antibodies and fragments, uses thereof, and methods of identifying same

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11014987
APP PUB NO 20170320950A1
SERIAL NO

15481410

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to antibodies and fragments that bind to a V-domain Ig Suppressor of T cell Activation (VISTA), and methods of eliciting certain biological responses using the antibodies. Compositions and methods of using anti-VISTA antibodies in combination with one or more antibodies that bind to immune checkpoint proteins are also provided.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • JANSSEN PHARMACEUTICS NV

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Marvel, Douglas Matthew Lansdale, US 4 32
Powers, Gordon Malvern, US 21 186
Snyder, Linda A Pottstown, US 22 53
Ubani, Enrique Zudaire Ambler, US 7 32

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Nov 25, 2024
7.5 Year Payment $3600.00 $1800.00 $900.00 Nov 25, 2028
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 25, 2032
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00